Mostrando 10 resultados de: 11
Filtros aplicados
Publisher
American Journal of Therapeutics(7)
Archivos Venezolanos de Farmacologia y Terapeutica(2)
Investigacion Clinica (Venezuela)(1)
Revista Latinoamericana de Hipertension(1)
Área temáticas
Enfermedades(9)
Fisiología humana(4)
Salud y seguridad personal(3)
Medicina forense; incidencia de enfermedades(2)
Bioquímica(1)
Área de conocimiento
Medicina interna(4)
Enfermedad cardiovascular(3)
Farmacología(3)
Infección(2)
Medicamento(2)
Ciprofibrate treatment decreases non-high density lipoprotein cholesterol and triglycerides and increases high density lipoprotein cholesterol in patients with frederickson type IV dyslipidemia phenotype
Conference ObjectAbstract: OBJECTIVE: The combination of hypertriglyceridemia and low high density lipoprotein (HDL) cholesteroPalabras claves:Ciprofibrate, Frederickson's type IV dyslipidemia, High density lipoprotein cholesterol, Hyperlipidemia, Low density lipoprotein cholesterol, Non-high density lipoprotein cholesterol, TriglyceridesAutores:Arráiz N., Bermúdez-Arias F., Cano-Peñaloza R., Cano-Ponce C., Contreras F., de Bravo M.C., De Diaz A.A., De Pirela N.L., Israili Z.H., Leal-Gonzalez E., Lemus-Antepaz M., Mengual-Moreno E., Puche-Medina G., Reyna-Villazmil N., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopusAn elevated level of physical activity is associated with normal lipoprotein(a) levels in individuals from Maracaibo, Venezuela
ArticleAbstract: Coronary artery disease is the main cause of death worldwide. Lipoprotein(a) [Lp(a)], is an independPalabras claves:Cardiovascular Risk, Lifestyle, lipoprotein(a), Physical activityAutores:Acosta L., Añez-Ramos R., Aparicio D., Arráiz N., Cano R.A., Cano-Ponce C., Colmenares C., Faria J., Finol F., Mengual-Moreno E., Peñaranda L., Pineda C., Rodriguez D., Rojas E.R., Rojas-Quintero J., Sanchez W., Sorell L.T., Toledo A.C., Urribarí J., Valmore Bermúdez, Velasco M.Fuentes:scopusFront-line medicines used in the treatment of tuberculosis
ArticleAbstract: Tuberculosis has emerged as an enormous global public health epidemic. Worldwide, it is the second lPalabras claves:Estreptomicin, Ethambutol, isoniazid, M. Tuberculosis, Pyrazinamide, rifampinAutores:Arráiz N., Bermúdez F.A., Leal E.M., Rodriguez M., Silva C., Valdelamar L., Valmore BermúdezFuentes:scopusInsulin resistance and hyperinsulinemia as risk factors for cardiovascular disease
Conference ObjectAbstract: Insulin resistance is defined as a metabolic state in which insulin peripheral effects are diminishePalabras claves:Cardiovascular disease, Hiperinsulinemia, Insulin, Insulin ResistanceAutores:Acosta L., Aparicio D., Arráiz N., Canelón R., Cano R.A., Deisiree S., Finol F., Leal E.M., Linares S., Luti Y., Rojas E.R., Rojas-Quintero J., Valmore BermúdezFuentes:scopusNovel mutations identification in exon 4 of LDLR gene in patients with moderate hypercholesterolemia in a venezuelan population
ArticleAbstract: Familial hypercholesterolemia (FH) is an autosomal dominant disease characterized by increase in lowPalabras claves:Coronary artery disease, Familial hypercholesterolemia, Frameshift mutations, LDL-receptor, PCR-SSCPAutores:Arráiz N., Borjas L., Carem Prieto, Mujica E., Reyes F., Reyna-Villasmil N., Rondón N., Solís E., Valmore Bermúdez, Velasco M.Fuentes:googlescopusOat-derived β-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia
Conference ObjectAbstract: OBJECTIVE: To investigate the effect of bread formulated with 6 g of β-glucan (oat soluble fiber) onPalabras claves:HDL cholesterol, LDL cholesterol, LDL cholesterol/HDL cholesterol ratio, Non-HDL cholesterol, Oat soluble fiber, Total cholesterol/HDL cholesterol ratio, β-glucanAutores:Arias N., Arráiz N., Cano-Ponce C., Hernández-Hernandez R., Inglett G.E., Israili Z.H., Leal-Gonzalez E., Mengual-Moreno E., Reyna-Villasmil N., Souki-Rincón A., Valasco M., Valmore BermúdezFuentes:scopusSerum lipoprotein (a) in patients post myocardial infarction
ArticleAbstract: Lipoprotein (a) [Lp (a)] is considered an independent risk factor for cardiovascular disease. In ourPalabras claves:Abdominal circumference, body mass index, dyslipidemia, Lipoprotein (a), myocardial infarctionAutores:Amell A., Añez-Ramos R., Arráiz N., Cano-Ponce C., Carem Prieto, Carrillo M., Cruz S., González M.C., Joselyn Zula, Montiel M., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Vergara P.M.Fuentes:googlescopusPPAR-γ agonists and their role in type 2 diabetes mellitus management
ReviewAbstract: Type 2 diabetes mellitus and obesity are the most frequent endocrine-metabolic diseases in the worldPalabras claves:diabetes mellitus, Insulin Resistance, PPARI, ThiazolidenedionesAutores:Arráiz N., Finol F., Parra M.G., Parra N., Peñaranda L., Pérez A., Rojas-Quintero J., Valmore Bermúdez, Velasco M., Vílchez D.Fuentes:scopusPrevalence of encephalitozoon intestinalis and enterocytozoon bieneusi in HIV positive patients to Maracaibo, Venezuela
ArticleAbstract: Microsporidioses are considered emerging and opportunistic infections in immunocompromised individuaPalabras claves:Encephalitozoon intestinalis, Enterocytozoon bieneusi, HIV/AIDS, PCR, VENEZUELAAutores:Ángela M. Bracho, Arráiz N., Perozo R.V., Sierra A.H., Zulbey Ch Rivero-RodríguezFuentes:googlescopusLipoprotein(a): From molecules to therapeutics
ReviewAbstract: Lipoprotein (a) [Lp(a)] was discovered by Kare Berg in 1963 from the study of low-density lipoproteiPalabras claves:Atherogenesis, Cardiovascular disease, Hyperlipoproteinemia(a), lipoprotein(a), therapeuticsAutores:Amell A., Aparicio D., Arráiz N., Cabrera M., Canelón R., Cano R.A., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Mengual-Moreno E., Reyna-Villasmil N., Rojas E.R., Sorell L.T., Valmore Bermúdez, Velasco M.Fuentes:scopus